Related references
Note: Only part of the references are listed.9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021
DIABETES CARE (2021)
Tubuloglomerular Feedback Synchronization in Nephrovascular Networks
Tayyaba Zehra et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Improving the Dysregulation of FoxO1 Activity Is a Potential Therapy for Alleviating Diabetic Kidney Disease
Yan Wang et al.
FRONTIERS IN PHARMACOLOGY (2021)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
The tubular hypothesis of nephron filtration and diabetic kidney disease
Volker Vallon et al.
NATURE REVIEWS NEPHROLOGY (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the Vasculature
Ivan Hernandez-Diaz et al.
DIABETES (2019)
Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis
K. Esmeijer et al.
SCIENTIFIC REPORTS (2019)
FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease
Fengjuan Huang et al.
EBIOMEDICINE (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States
Rajiv Saran et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
N. H. Cho et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study
Giuseppe Penno et al.
DIABETOLOGIA (2018)
Diabetic nephropathy: Is there a role for oxidative stress?
Manpreet K. Sagoo et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Glomerular Endothelial Cells Stress and Cross-Talk with Podocytes in the Development of Diabetic Kidney Disease
Ilse Sofia Daehn
FRONTIERS IN MEDICINE (2018)
The Susceptibility Genes in Diabetic Nephropathy
Ling Wei et al.
KIDNEY DISEASES (2018)
Renal, metabolic and cardiovascular considerations of SGLT2 inhibition
Ralph A. DeFronzo et al.
NATURE REVIEWS NEPHROLOGY (2017)
Inhibition of Reticulon-1A-Mediated Endoplasmic Reticulum Stress in Early AKI Attenuates Renal Fibrosis Development
Ying Fan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Non-Diabetic Kidney Disease in Type 2 Diabetic Patients: Prevalence, Clinical Predictors and Outcomes
Siyar Erdogmus et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2017)
Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
Aidin Rawshani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Presentation, pathology and prognosis of renal disease in type 2 diabetes
Jasmine Tan et al.
BMJ OPEN DIABETES RESEARCH & CARE (2017)
NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy
Jay C. Jha et al.
DIABETES (2017)
Diabetes and Hypertension: A Position Statement by the American Diabetes Association
Ian H. de Boer et al.
DIABETES CARE (2017)
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus
Giuseppe Penno et al.
DIABETOLOGIA (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy
Jay C. Jha et al.
DIABETOLOGIA (2016)
Lentiviral Vector-Mediated FoxO1 Overexpression Inhibits Extracellular Matrix Protein Secretion Under High Glucose Conditions in Mesangial Cells
Feng Guo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice
Hajime Nagasu et al.
LABORATORY INVESTIGATION (2016)
Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease
Merlin C. Thomas et al.
NATURE REVIEWS NEPHROLOGY (2016)
Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation
Minah Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Tie1 controls angiopoietin function in vascular remodeling and inflammation
Emilia A. Korhonen et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Tie1: an orphan receptor provides context for angiopoietin-2/Tie2 signaling
Sarah B. Mueller et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms
Luigi Gnudi et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
The Bioenergetic Health Index is a sensitive measure of oxidative stress in human monocytes
Balu K. Chacko et al.
REDOX BIOLOGY (2016)
Renoprotective Effects of Atorvastatin in Diabetic Mice: Downregulation of RhoA and Upregulation of Akt/GSK3
Thiago Bruder-Nascimento et al.
PLOS ONE (2016)
Effects of FoxO1 on podocyte injury in diabetic rats
Feng Guo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Ras transformation results in cleavage of reticulon protein Nogo-B that is associated with impairment of IFN response
Dae-Gyun Ahn et al.
CELL CYCLE (2015)
Vascular growth factors play critical roles in kidney glomeruli
Luigi Gnudi et al.
CLINICAL SCIENCE (2015)
Mitochondrial Hormesis and Diabetic Complications
Kumar Sharma
DIABETES (2015)
Activation of FoxO1/PGC-1α prevents mitochondrial dysfunction and ameliorates mesangial cell injury in diabetic rats
Lina Wu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Renoprotective Effects of Fenofibrate via Modulation of LKB1/AMPK mRNA Expression and Endothelial Dysfunction in a Rat Model of Diabetic Nephropathy
Nawal M. Al-Rasheed et al.
PHARMACOLOGY (2015)
Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial
Dick de Zeeuw et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Altered Mitochondrial Function, Mitochondrial DNA and Reduced Metabolic Flexibility in Patients With Diabetic Nephropathy
Anna Czajka et al.
EBIOMEDICINE (2015)
Hypoglycemia in Patients with Diabetes and Renal Disease
Mazen Alsahli et al.
JOURNAL OF CLINICAL MEDICINE (2015)
Endoplasmic Reticulum Stress in the Diabetic Kidney, the Good, the Bad and the Ugly
Robyn Cunard
JOURNAL OF CLINICAL MEDICINE (2015)
Non-Proteinuric Diabetic Nephropathy
Nicolas Roberto Robles et al.
JOURNAL OF CLINICAL MEDICINE (2015)
Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development
Hyun Mi Kang et al.
NATURE MEDICINE (2015)
Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes
Yves Gorin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Abnormal lipoprotein metabolism in diabetic nephropathy
Tsutomu Hirano
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2014)
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Katherine R. Tuttle et al.
DIABETES CARE (2014)
Activation of Glycogen Synthase Kinase 3β Ameliorates Diabetes-induced Kidney Injury
Meenalakshmi M. Mariappan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Targeted Glomerular Angiopoietin-1 Therapy for Early Diabetic Kidney Disease
Cecile Dessapt-Baradez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Role of Endothelial Nitric Oxide Synthase in Diabetic Nephropathy: Lessons from Diabetic eNOS Knockout Mice
Takamune Takahashi et al.
JOURNAL OF DIABETES RESEARCH (2014)
Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study
Ian H. de Boer et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Tubulointerstitial disease in diabetic nephropathy
Giancarlo Tonolo et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2014)
Mammalian Target of Rapamycin Regulates Nox4-Mediated Podocyte Depletion in Diabetic Renal Injury
Assaad A. Eid et al.
DIABETES (2013)
Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function
Elif I. Ekinci et al.
DIABETES CARE (2013)
AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function
Laura L. Dugan et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells
Ping Gao et al.
JOURNAL OF NEPHROLOGY (2013)
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
Vlado Perkovic et al.
KIDNEY INTERNATIONAL (2013)
FOXOs: signalling integrators for homeostasis maintenance
Astrid Eijkelenboom et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
A Glimpse of the Pathogenetic Mechanisms of Wnt/β-Catenin Signaling in Diabetic Nephropathy
Li Xiao et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Nutrient Sensing, Autophagy, and Diabetic Nephropathy
Shinji Kume et al.
DIABETES (2012)
eNOS Deficiency Predisposes Podocytes to Injury in Diabetes
Darren A. Yuen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
VEGF and angiopoietins in diabetic glomerulopathy: How far for a new treatment?
Alessandra Dei Cas et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
The proximal tubule in the pathophysiology of the diabetic kidney
Volker Vallon
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2011)
Podocyte vascular endothelial growth factor (Vegf 164 ) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes
D. Veron et al.
DIABETOLOGIA (2011)
Effects of Lipid-Lowering Therapy with Rosuvastatin on Kidney Function and Oxidative Stress in Patients with Diabetic Nephropathy
Masanori Abe et al.
Journal of Atherosclerosis and Thrombosis (2011)
Angiopoietin-1 is essential in mouse vasculature during development and in response to injury
Marie Jeansson et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
Markus Goedel et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes
Giuseppe Penno et al.
JOURNAL OF HYPERTENSION (2011)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
Hermann Haller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes
Ian H. de Boer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
GSK3β inactivation in podocytes results in decreased phosphorylation of p70S6K accompanied by cytoskeletal rearrangements and inhibited motility
Britta George et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Nogo-B receptor is essential for angiogenesis in zebrafish via Akt pathway
Baofeng Zhao et al.
BLOOD (2010)
Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function
Gavin I. Welsh et al.
CELL METABOLISM (2010)
AMP-activated Protein Kinase (AMPK) Negatively Regulates Nox4-dependent Activation of p53 and Epithelial Cell Apoptosis in Diabetes
Assaad A. Eid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Proteinuria in Diabetes: Bystander or Pathway to Cardiorenal Disease?
Janaka Karalliedde et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Pathologic Classification of Diabetic Nephropathy
Thijs W. Cohen Tervaert et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
Faramarz Ismail-Beigi et al.
LANCET (2010)
The RAAS in the pathogenesis and treatment of diabetic nephropathy
Piero Ruggenenti et al.
NATURE REVIEWS NEPHROLOGY (2010)
The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse
Sara Giunti et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Abnormal Angiogenesis in Diabetic Nephropathy
Takahiko Nakagawa et al.
DIABETES (2009)
Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11)
Merlin C. Thomas et al.
DIABETES CARE (2009)
Wnt/β-Catenin Signaling Promotes Podocyte Dysfunction and Albuminuria
Chunsun Dai et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes
Toshiharu Ninomiya et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes.
Michael Mauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
William Duckworth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse
Takahiro Nakayama et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: A pooled analysis
George Jerums et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice
Ching-Hsin Ku et al.
DIABETES (2008)
RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease
Fangfang Peng et al.
DIABETES (2008)
Oxidative stress as a major culprit in kidney disease in diabetes
Josephine M. Forbes et al.
DIABETES (2008)
What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?
S. C. Satchell et al.
DIABETOLOGIA (2008)
In Vivo Modulation of Nogo-B Attenuates Neointima Formation
Angelika B. Kritz et al.
MOLECULAR THERAPY (2008)
VEGF inhibition and renal thrombotic microangiopathy
Vera Eremina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Long-term follow-up after tight control of blood pressure in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of a multifactorial intervention on mortality in type 2 diabetes
Peter Gaede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Properties of the glomerular barrier and mechanisms of proteinuria
Borje Haraldsson et al.
PHYSIOLOGICAL REVIEWS (2008)
Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control
Vasantha Kolavennu et al.
DIABETES (2008)
MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy
G. H. Tesch
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Mechanical forces in diabetic kidney disease: A trigger for impaired glucose metabolism
Luigi Gnudi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia
Belinda Davis et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Low levels of Nogo-B in human carotid atherosclerotic plaques are associated with an atheromatous phenotype, restenosis, and stenosis severity
Juan A. Rodriguez-Feo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes
Bruce A. Perkins et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Cellular and molecular mechanisms of proteinuria in diabetic nephropathy
Gunter Wolf et al.
NEPHRON PHYSIOLOGY (2007)
Histopathology of diabetic nephropathy
Paola Fioretto et al.
SEMINARS IN NEPHROLOGY (2007)
Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes
Murray Epstein et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells
Robert Qing Miao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease?
Richard J. MacIsaac et al.
DIABETES CARE (2006)
Risk factors for renal dysfunction in type 2 diabetes - UK prospective diabetes study 74
Ravi Retnakaran et al.
DIABETES (2006)
A class of membrane proteins shaping the tubular endoplasmic reticulum
GK Voeltz et al.
CELL (2006)
Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes
H Rahmoune et al.
DIABETES (2005)
Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney
Y Gorin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The human glomerular podocyte is a novel target for insulin action
RJM Coward et al.
DIABETES (2005)
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the Irbesartan Diabetic Nephropathy Trial: Clinical implications and limitations
MA Pohl et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
TGF-β impairs renal autoregulation via generation of ROS
K Sharma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaernic control, endothelial damage/dysfunction and atherosclerosis
HS Lim et al.
ATHEROSCLEROSIS (2005)
The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease
L Raij
AMERICAN JOURNAL OF HYPERTENSION (2005)
Role of lipid control in diabetic nephropathy
HC Chen et al.
KIDNEY INTERNATIONAL (2005)
Glycogen-synthase kinase3β/β-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells
C Skurk et al.
CIRCULATION RESEARCH (2005)
A new role for Nogo as a regulator of vascular remodeling
L Acevedo et al.
NATURE MEDICINE (2004)
Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance
M Vedovato et al.
DIABETOLOGIA (2004)
Preventing microalbuminuria in type 2 diabetes
P Ruggenenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Nonalbuminuric renal insufficiency in type 2 diabetes
R MacIsaac et al.
DIABETES CARE (2004)
Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria
P Gæde et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans
BA Young et al.
DIABETES CARE (2003)
GLUT-1 overexpression - Link between hemodynamic and metabolic factors in glomerular injury?
L Gnudi et al.
HYPERTENSION (2003)
Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus
HJ Kramer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
P Gaede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy
ME Cooper
DIABETOLOGIA (2001)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
HH Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: Role of nitric oxide
AS De Vriese et al.
KIDNEY INTERNATIONAL (2001)
Progression of diabetic nephropathy
P Hovind et al.
KIDNEY INTERNATIONAL (2001)
High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells
T Inoguchi et al.
DIABETES (2000)
Share Paper
